Fusion Between TMPRSS2 and ETS Family Members (ERG, ETV1, ETV4) in Prostate Cancers from Northern China |
Wang, Jian-Jiang
(Department of Urology, Beijing Tongren Hospital, Capital Medical University)
Liu, Yue-Xin (Department of Urology, Beijing Tongren Hospital, Capital Medical University) Wang, Wei (Department of Urology, Beijing Tongren Hospital, Capital Medical University) Yan, Wei (Department of Urology, Beijing Tongren Hospital, Capital Medical University) Zheng, Yu-Peng (Department of Urology, Beijing Tongren Hospital, Capital Medical University) Qiao, Lu-Dong (Department of Urology, Beijing Tongren Hospital, Capital Medical University) Liu, Dan (Department of Urology, Beijing Tongren Hospital, Capital Medical University) Chen, Shan (Department of Urology, Beijing Tongren Hospital, Capital Medical University) |
1 | Darnel AD, Lafargue CJ, Vollmer RT, Corcos J, Bismar TA (2009). TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort. Cancer Biol Ther, 8, 125-30. DOI |
2 | Huang L, Schauer IG, Zhang J, et al (2011). The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer. Int J Clin Exp Pathol, 4, 644-50. |
3 | Lee K, Chae JY, Kwak C, Ku JH, Moon KC(2010). TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients. Urology, 76, 1267-8. |
4 | Mao X, Yu Y,Boyd LK, et al (2010). Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res, 70, 5207-12. DOI |
5 | Rubio-Briones J, Fernandez-Serra A, Calatrava A, et al (2010). Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy. J Urol, 183, 2054-61. DOI |
6 | Song FJ, Zhang BL, He M, et al (2010). Trend analysis of the incidence of prostate cancer in Tianjin between 1981 and 2004. Zhonghua Yi Xue Za Zhi, 90, 2811-4. |
7 | Sun QP, Li LY,Chen Z, et al (2010). Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot study. J Mol Diag, 12, 718-24. DOI ScienceOn |
8 | Sun YH (2004). Research on prostate cancer in China. Chin J Urol, 25, 77-80. |
9 | Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I (2000). Expression of c-Ets1 is associated with malignant potential in endometrial carcinoma. Cancer, 89, 2059-67. DOI |
10 | Tomlins SA, Mehra R,Rhodes DR, et al (2006). TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res, 66, 3396-400. DOI |
11 | Tomlins SA, Rhodes DR,Perner S, et al (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310, 644-8. DOI ScienceOn |
12 | Weir HK, Thun MJ, Hankey BF, et al (2003). Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst, 95, 1276-99. DOI |
![]() |